Press - MariMed

MariMed Introduces World-Famous ‘Tikun Olam’ Genetics, Flower and Products into Massachusetts Market

Tikun Olam is Israel’s premier medical cannabis company with over 10 years of on-the-ground and clinical data depicting how its unique genetics affected medical patients with specific conditions including Crohn's Disease, Epilepsy, PTSD, MS, and chronic pain MariMed’s licensed subsidiary ARL Healthcare cultivates Tikun cannabis and will distribute its products at its Panacea Wellness Dispensary...

MariMed Launches “ElderBetty Chews”

Betty’s Eddies™ Brand’s New and Innovative Product First to market elderberry cannabis edible Rich in antioxidants, vitamins, and minerals Now available in Massachusetts, Maryland, Nevada, and Rhode Island NORWOOD, Mass., Oct. 29, 2020 (GLOBE NEWSWIRE) -- With cold & flu season approaching, leading multi-state cannabis and hemp operator MariMed Inc. (MRMD:OTCQX) (the “Company” or “MariMed”)...

MariMed’s Best-Selling Betty’s Eddies™ and Kalm Fusion™ Brands Now Available in Puerto Rico

Products Manufactured and Distributed by Tropizen LLC, Marimed’s Puerto Rico strategic partner MariMed Manufactures and Distributes Tropizen’s Popular Infused “ Hot Sauce” Product in the States NORWOOD, Mass., Sept. 23, 2020 (GLOBE NEWSWIRE) -- MariMed Inc. (MRMD:OTCQX) (the “Company” or “MariMed”), a leading multi-state cannabis and hemp operator focused on health and wellness, is pleased to...

MariMed Granted Approval to Open its Third Adult Use Dispensary in Illinois

NORWOOD, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) -- MariMed Inc. (MRMD:OTCQX) (the “Company” or “MariMed”), a leading multi-state cannabis and hemp operator focused on health and wellness, today announced it received an adult use license from the Illinois Department of Financial and Professional Regulation for its third adult use dispensary in Illinois. The dispensary is in Mount Vernon, IL, and...

MariMed To Commence Adult-Use Operations at Panacea Wellness Dispensary in Middleborough, Massachusetts

NORWOOD, Mass., Sept. 14, 2020 (GLOBE NEWSWIRE) -- MariMed Inc. (MRMD:OTCQX) (the “Company” or “MariMed”), a leading multi-state cannabis and hemp operator focused on health and wellness, today announced that the Massachusetts Cannabis Control Commission (“CCC”) completed its final inspection and has authorized MariMed’s Panacea Wellness Dispensary in Middleborough, Massachusetts to commence...

MariMed’s Illinois Thrive Dispensary Donates $10,000 to City of Harrisburg

NORWOOD, Mass., Aug. 19, 2020 (GLOBE NEWSWIRE) -- MariMed Inc. (MRMD:OTCQX,) a leading multi-state cannabis and hemp operator focused on health and wellness, announced today that their Illinois dispensary in Harrisburg, which operates under the Thrive brand, donated $10,000 to the city of Harrisburg, for public health and safety measures in the community.

MariMed Nature’s Heritage Flower Brand Expands Product Offerings to Meet Strong Consumer Demand

Launched February 2020, Nature’s Heritage has quickly become a top selling flower brand in Massachusetts Capitalizing on high consumer demand, Nature’s Heritage will expand its product offerings to include concentrates, vaporizers, and pre-rolls in Q3 2020 NORWOOD, Mass., July 30, 2020 (GLOBE NEWSWIRE) -- MariMed Inc. (MRMD:OTCQX) (the “Company” or “MariMed”), a leading multi-state cannabis and...

MariMed Launches Award Winning Betty’s Eddies™ Edibles In Nevada Adult Use Cannabis Market

NORWOOD, Mass., April 21, 2020 (GLOBE NEWSWIRE) -- MariMed Inc. (MRMD:OTCQX) (the “Company” or MariMed), a leading multi-state cannabis and hemp operator focused on health and wellness, announced today that Betty's Eddies™, its proprietary, in-house award-winning national cannabis brand, will now be available for retail purchase in Nevada. The expansion is part of MariMed’s plan to increase the...

An Update on MariMed's COVID-19 Response

MariMed is monitoring the spread of COVID-19 in the U.S. and proactively working across each of our business units to minimize its impact on the supply chain. Our first priority is to ensure medical cannabis patients continue to have access to the medicine they need at a time when they may be especially vulnerable. While we have not yet experienced significant disruption to our core cannabis...